In the year since it was officially introduced in the United States, Lovaza is on target to top $1 billion in sales this year. The success of this prescription-only omega-3 fish oil capsule from GlaxoSmithKline opens a whole new door for Big Pharma, which has a deepening interest in natural substances to prevent and treat health conditions. “The pharmaceutical industry is opening itself up to considering natural substances and their clinical benefits,” said Bernardette King, a GSK ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

Why Register for FREE?

Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.  What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
 

Click here to read the FAQ page if you have any questions (opens in a new window)
 

Attention Paid Print Subscribers:  While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.